AHA Scientific Sessions 2012

Join the CSRC during the AHA Scientific Sessions on November 7, 2012 in Los Angeles, California.

The CSRC will have a morning session (7:30am-8:45am) on Cardiac Safety and Cancer Treatment.

See the session program and speakers below.

Cardiac Disease and Safety with Cancer Treatment: A Compelling Need for Cooperation

Moderators: Mitchell Krucoff, MD (Duke) and David Slosky, MD (Vanderbilt)

  • Cardiac Safety During Chemotherapy: The Scope of the Problem: Daniel Lenihan, MD (Vanderbilt)
  • How Do We Effectively Ensure Cardiac Safety During Drug Development?: John Finkle, MD (GlaxoSmithKline)
  • Is There an Equation for Risk : Benefit in Drug Development that can be a Regulatory Guide: Norman Stockbridge, MD, PhD (FDA)
  • Standardization of Cardiac Event Reporting is Critical to Understanding Cardiac Safety Issues: Scot Remick, MD (West Virginia University)
  • Are We Creating More Stage A Heart Failure Patients with Chemotherapy?: Jean-Bernard Durand, MD (MD Anderson)